The global Ayurveda export strategy outlined by NITI Aayog aims to transform Ayurveda into a globally recognized healthcare system by 2047. This significant development, detailed in the ‘Strategic Roadmap for Making Ayurveda Global,’ is a bold initiative to elevate Ayurveda from a regional wellness practice to a major player in international healthcare. The plan’s comprehensive approach targets international recognition, enhanced research, manufacturing upgrades, and the promotion of medical tourism, forecasting a dynamic transformation in the traditional medicine landscape.
Global Ayurveda Export Strategy: Vision for 2047
NITI Aayog’s strategy aligns with India’s aspirational Viksit Bharat@2047 vision, aiming to establish Ayurveda as a credible, global healthcare alternative, grounded in evidence-based practices. Ashok Kumar Lahiri, NITI Aayog Vice Chairman, emphasizes the pragmatic and ambitious scope of this roadmap, which spans several decades and promises to align Ayurveda with established global healthcare standards.
Phased Approach towards Global Integration
The roadmap proposes a phased strategy that addresses existing barriers limiting Ayurveda’s global reach, such as fragmented regulations and limited scientific validation. The phased approach seeks to gradually overcome these hurdles to improve international access and acceptance. Additionally, it includes the development of mutually beneficial recognition agreements with foreign nations to foster international collaboration and integration.
Strengthening Research and Development
Central to this initiative is strengthening evidence-based research. The report advocates for the establishment of an International Ayurveda Research Alliance and more WHO collaborating centers. This focus on research aims to generate robust clinical evidence, thereby boosting the credibility of Ayurveda based products globally. Moreover, collaborations between industry and academia are encouraged to foster innovation and clinical trials, further integrating Ayurveda within the conventional scientific framework. This strategy aligns with broader trends of technological innovation in healthcare.
Upgrading Manufacturing Standards
To facilitate competitive manufacturing and exports, the roadmap emphasizes adhering to WHO-GMP norms for production. It suggests creating an export-focused Ayurvedic Pharmacopoeia and setting up overseas finishing units. These measures aim to enhance product quality and safety standards, pivotal for increasing the international market share of Ayurvedic products. By doing so, the initiative seeks to transition these products from dietary supplements to higher value finished goods, thus opening new economic avenues.
Expanding Medical Value Travel
Promoting medical value travel forms a critical component of the strategy, leveraging India’s rich cultural and medical heritage to attract international patients seeking Ayurvedic treatment. This aspect not only boosts the service economy but also enhances cultural diplomacy, showcasing Ayurveda as an integrated part of holistic healthcare.
In conclusion, the roadmap to globalize Ayurveda symbolizes a transformative agenda that could redefine traditional medicine on the international stage. By focusing on evidence-based practices, scaling up research, and enhancing manufacturing competitiveness, India is poised to position Ayurveda as a major export and healthcare system by 2047.
Key Takeaways
- The strategy aims to establish Ayurveda as a globally recognized healthcare option by 2047.
- Strengthening research and improving manufacturing standards are key components of the plan.
- The initiative promotes economic growth through enhanced exports and medical tourism.
Medical Disclaimer
This article provides informational content based on currently available data and findings.
